Skip to content
healthcare.dev

Everolimus

NDC 0054-0497, Everolimus, tablet, from Hikma Pharmaceuticals USA Inc..

Product NDC
0054-0497
Status
Listed
Labeler
Hikma Pharmaceuticals USA Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207486
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0054-0497 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • EVEROLIMUS7.5 mg/1

Pharmacologic classes

Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Decreased Immunologic Activity [PE]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]; mTOR Inhibitor Immunosuppressant [EPC]; mTOR Inhibitors [MoA]

Package NDCNDC-11Package
0054-0497-130005404971330 TABLET in 1 BOTTLE (0054-0497-13)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5aaf2fb7-93f6-40d6-941a-9583a3794ce7

Use it

Look up 0054-0497 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0054-0497 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0054-0497. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.